Farther Finance Advisors’s Capricor Therapeutics CAPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$867 Hold
36
﹤0.01% 5409
2026
Q1
$1.08K Sell
36
-3
-8% -$80 ﹤0.01% 5089
2025
Q4
$1.13K Sell
39
-3,846
-99% -$50.2K ﹤0.01% 4881
2025
Q3
$28K Buy
+3,885
New +$28.6K ﹤0.01% 2810

Other funds holding CAPR

Farther Finance Advisors's CAPR Position: Q2 2026 in Review

Farther Finance Advisors held its Capricor Therapeutics (CAPR) position steady in Q2 2026 at 36 shares worth $867. The position accounts for ﹤0.01% of the portfolio, ranked #5409.

Farther Finance Advisors first reported a position in CAPR in Q3 2025 and has held it in 4 quarters since. The position peaked at $28K in Q3 2025. 7 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • Farther Finance Advisors held 36 shares of Capricor Therapeutics worth $867 as of Q2 2026.
  • Farther Finance Advisors left its Capricor Therapeutics share count unchanged in Q2 2026.
  • Capricor Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5409 holding.
  • Farther Finance Advisors first reported a position in Capricor Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Farther Finance Advisors's Capricor Therapeutics position peaked at $28K in Q3 2025.
  • 7 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.